IDEAYA Biosciences Inc (IDYA)
26.79
+0.19
(+0.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.77
-0.02
(-0.07%)
After-Hours: 20:00
IDEAYA Biosciences Total Liabilities (Quarterly): 59.46M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.46M |
| June 30, 2024 | 42.00M |
| March 31, 2024 | 26.22M |
| December 31, 2023 | 28.23M |
| September 30, 2023 | 24.89M |
| June 30, 2023 | 25.95M |
| March 31, 2023 | 30.94M |
| December 31, 2022 | 38.51M |
| September 30, 2022 | 42.14M |
| June 30, 2022 | 68.69M |
| March 31, 2022 | 70.20M |
| December 31, 2021 | 79.83M |
| Date | Value |
|---|---|
| September 30, 2021 | 81.82M |
| June 30, 2021 | 88.14M |
| March 31, 2021 | 92.97M |
| December 31, 2020 | 100.00M |
| September 30, 2020 | 105.96M |
| June 30, 2020 | 12.45M |
| March 31, 2020 | 12.69M |
| December 31, 2019 | 12.60M |
| September 30, 2019 | 11.92M |
| June 30, 2019 | 12.75M |
| March 31, 2019 | 12.35M |
| December 31, 2018 | 145.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.45M
Minimum
Jun 2020
105.96M
Maximum
Sep 2020
52.18M
Average
42.07M
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 36.14B |
| Vertex Pharmaceuticals Inc | 6.609B |
| Black Diamond Therapeutics Inc | 40.47M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.240B |
| Shareholders Equity (Quarterly) | 1.180B |